In vitro antimicrobial activity of nanoconjugated vancomycin against drug resistant Staphylococcus aureus

International Journal of Pharmaceutics

Volumn 436, Issue 1-2, 2012, Pages 659-676

  Chakraborty, Subhankari Prasad ^a   Sahu, Sumanta Kumar ^b   Pramanik, Panchanan ^b   Roy, Somenath ^a  

^a VIDYASAGAR UNIVERSITY   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Cell viability; Cell wall thickness; Minimum inhibitory concentration; Na +, K+ ATPase activity; Nanoconjugated vancomycin; Vancomycin resistant Staphylococcus aureus

Indexed keywords

CHITOSAN; FOLIC ACID; NANOCONJUGATED VANCOMYCIN; NANOPARTICLE; UNCLASSIFIED DRUG; VANCOMYCIN;

AGAR DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BIOFILM; CELL VIABILITY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG TOLERANCE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TRANSMISSION ELECTRON MICROSCOPY;

ADSORPTION; ANTI-BACTERIAL AGENTS; CHITOSAN; DIETHYLAMINES; DRUG RESISTANCE, BACTERIAL; FOLIC ACID; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; POTASSIUM; SODIUM-POTASSIUM-EXCHANGING ATPASE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 84865301218     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.07.033     Document Type: Article

References (67)

1. The disc susceptibility test J.F. Acar, and V. Lorian Antibiotics in Laboratory Medicine 1980 Williams and Wilkins Co. Baltimore 24 25
2. G.L. Archer, and M.W. Climo Staphylococcus aureus bacteremia - consider the source N. Engl. J. Med. 344 2001 55 56
3. M.R. Avadi, A.M.M. Sadeghi, A. Tahzibi, M. Bayati Kh Pouladzadeh, M.J. Zohuriaan-Mehr, and M. Rafiee-Tehrani Diethylmethyl chitosan as an antimicrobial agent: synthesis, characterization and antibacterial effects Eur. Polym. J. 40 2004 1355 1361
4. A.W. Bauer, W.M.M. Kirby, J.C. Sherris, and M. Turch Antibiotic susceptibility testing by a standardized single disk method Am. J. Clin. Pathol. 45 1966 493 496
5. R. Bax, R. Bywater, G. Cornaglia, H. Goossens, P. Hunter, V. Isham, V. Jarlier, R. Jones, I. Phillips, D. Sahm, S. Senn, M. Struelens, D. Taylor, and A. White Surveillance of antimicrobial resistance - what, how and whither? Clin. Microbiol. Infect. 7 2001 316 325
6. E. Breukink, I. Wiedemann, C. Van Kraaij, O. Kuipers, H. Sahl, and B. De Kruijff Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic Science 286 1999 2361 2364
7. M.T. Cabeen, and C. Jacobs-Wagner Bacterial cell shape Nat. Rev. Microbiol. 3 2005 601 610
8. E. Cevher, Z. Orhan, L. Mulazimoglu, D. Sensoy, M. Alper, A. Yildiz, and Y. Ozsoy Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres Int. J. Pharm. 317 2006 127 135
9. S.P. Chakraborty, S.K. Sahu, P. Pramanik, and S. Roy Biocompatibility of folate-modified chitosan nanoparticles Asian Pac. J. Trop. Biomed. 2 2012 215 219
10. S.P. Chakraborty, S. Kar Mahapatra, S.K. Sahu, P. Pramanik, and S. Roy Antioxidative effect of folate-modified chitosan nanoparticles Asian Pac. J. Trop. Biomed. 1 2011 29 38
11. S.P. Chakraborty, S. Kar Mahapatra, M. Bal, and S. Roy Isolation and identification of vancomycin resistant Staphylococcus aureus from post operative pus sample Al Ameen J. Med. Sci. 4 2011 152 168
12. S.P. Chakraborty, S.K. Sahu, S. Kar Mahapatra, S. Santra, M. Bal, S. Roy, and P. Pramanik Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents Nanotechnology 21 2010 105103
13. H.F. Chambers The changing epidemiology of Staphylococcus aureus? Emerg. Infect. Dis. 7 2001 178 182
14. S. Chang, D.M. Sievert, J.C. Hageman, M.L. Boulton, F.C. Tenover, F.P. Downes, S. Shah, J.T. Rudrik, G.R. Pupp, W.J. Brown, D. Cardo, and S.K. Fridkin Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene N. Engl. J. Med. 348 2003 1342 1347
15. X.G. Chen, and H.J. Park Chemical characteristics of O-carboxymethyl chitosans related to the preparation conditions Carbohydr. Polym. 53 2003 355 359
16. B.K. Choi, K.Y. Kim, Y.J. Yoo, S.J. Oh, J.H. Choi, and C.Y. Kim In vitro antimicrobial activity of a chitooligoaccharide mixture against Actinobacillus actinomycetemcomitans and Streptococcus mutants Int. J. Antimicrob. Agents 18 2001 553 557
17. W.G. Chou, and B.M. Pogell Mode of action of pamamycin in Staphylococcus aureus Antimicrob. Agents Chemother. 20 1981 443 454
18. L. Cui, H. Murakami, K.K. Arai, H. Hanaki, and K. Hiramatsu Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50 Antimicrob. Agents Chemother. 44 2000 2276 2285
19. V.M. D'Costa, K.M. McGrann, D.W. Hughes, and G.D. Wright Sampling the antibiotic resistome Science 311 2006 374 377
20. A.M. De Campos, Y. Diebold, E.L.S. Carvalho, A. Sanchez, and M.J. Alonso Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity Pharm. Res. 21 2004 803 810
21. P. Eaton, J.C. Fernandes, E. Pereira, M.E. Pintado, and F.X. Malcata Atomic force microscopy study of the antibacterial effects of chitosans on Escherichia coli and Staphylococcus aureus Ultramicroscopy 108 2008 1128 1134
22. G.M. Eliopoulos, and R.C. Moellering Antimicrobial combinations V. Lorian, Antibiotics in Laboratory Medicine 3rd ed. 1991 Williams and Wilkins Co. Baltimore 432 492
23. M. Garcia-Fuentes, N. Csaba, and M.J. Alonso Nanostructured chitosan carriers for oral protein and peptide delivery Drug Deliv. Ed. Touch Briefings 2007 16 19
24. E. Guibal Interactions of metal ions with chitosan-based sorbents: a review Sep. Purif. Technol. 38 2004 43 74
25. D. Herbert, P.J. Phipps, and R.E. Strange Chemical analysis of microbial cells J.R. Norris, D.W. Ribbons, Methods in Microbiology 1971 Academic Press London, United Kingdom 209 344
26. K. Hiramatsu Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance Lancet Infect. Dis. 1 2001 147 155
27. K. Hiramatsu Vancomycin resistance in Staplylococci Drug Resist. 1 1998 135 150
28. K. Hiramatsu, H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F.C. Tenover Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility J. Antimicrob. Chemother. 40 1997 135 146
29. M.P. Jevons Celbenin-resistant Staphylococci BMJ 1 1961 124 125
30. T. Kean, and M. Thanou Biodegradation, biodistribution and toxicity of chitosan Adv. Drug Deliv. Rev. 62 2010 3 11
31. T.H. Kim, I.K. Park, J.W. Nah, Y.J. Choi, and C.S. Cho Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier Biomaterials 25 2004 3783 3792
32. W.M.M. Kirby Extraction of a highly potent penicillin inactivator from penicillin resistant Staphylococci Science 99 1944 452 453
33. C.M. Lauriano, C. Ghosh, N.E. Correa, and K.E. Klose The sodium-driven flagellar motor controls exopolysaccharide expression in Vibrio cholerae J. Bacteriol. 186 2004 4864 4874
34. L. Leon, and L. Moujir Activity and mechanism of the action of zeylasterone against Bacillus subtilis J. Appl. Microbiol. 104 2008 1266 1274
35. T.P. Levin, B. Suh, P. Axelrod, A.L. Truant, and T. Fekete Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure Antimicrob. Agents Chemother. 49 2005 1222 1224
36. Q. Li, S. Mahendra, D.Y. Lyon, L. Brunet, M.V. Liga, D. Li, and P.J.J. Alvarez Antimicrobial nanomaterials for water disinfection and microbial control: potential applications and implications Water Res. 42 2008 4591 4602
37. X.F. Liu, Y.L. Guan, D.Z. Yang, Z. Li, and K.D. Yao Antibacterial action of chitosan and carboxymethylated chitosan J. Appl. Polym. Sci. 79 2001 1324 1335
38. D.M. Livermore The need for new antibiotics Clin. Microbiol. Infect. 10 2004 1 9
39. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the folin-phenol reagent J. Biol. Chem. 193 1951 265 275
40. +-ATPase activity in the rat brain is mediated through a1A adrenoceptor possibly by dephosphorylation of the enzyme J. Neurochem. 74 2000 1574 1578
41. H.Q. Mao, K. Roy, V.L. Troung-Le, K.A. Janes, K.Y. Lin, Y. Wang, J.T. August, and K.W. Leong Chitosan-DNA nanoparticles as gene carrier: synthesis, characterization and transfection efficiency J. Control. Release 70 2001 399 421
42. D. Mason, R. Allman, and D. Lloyd Uses of membrane potential sensitive dyes with bacteria D. Lloyd, Flow Cytometry in Microbiology 1993 Springer London 67 82
43. J. May, K. Shannon, and A. King Glycopeptide tolerance in Staphylococcus aureus J. Antimicrob. Chemother. 42 2006 189 197
44. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
45. R.A.A. Muzzarelli, R. Tarsi, O. Filippini, E. Giovanetti, G. Biagini, and P. Varaldo Antimicrobial properties of N-carboxybutyl chitosan Antimicrob. Agents Chemother. 34 1990 2019 2033
46. NCCLS, 2000. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 5th ed.; vol. 17, no. 2. Approved standard M7-A5. Wayne, PA, NCCLS.
47. W.S.W. Ngah, and K.H. Liang Adsorption of gold(III) ions onto chitosan and N-carboxymethyl chitosan: equilibrium studies Ind. Eng. Chem. Res. 38 1999 1411 1414
48. V.C. Okore Evaluation of chemical antimicrobial agents. Bacterial resistance to antimicrobial agents Pharm. Microbiol. 55 2005 120
49. A. Portero, C. Remunan-Lopez, M.T. Criado, and M.J.J. Alonso Microencapsulation 19 2002 797 809
50. M. Potara, E. Jakab, A. Damert, O. Popescu, V. Canpean, and S. Astilean Synergistic antibacterial activity of chitosan-silver nanocomposites on Staphylococcus aureus Nanotechnology 22 2011 135101 10.1088/0957-4484/22/13/ 135101 9 pp.
51. L. Qi, Z. Xu, X. Jiang, C. Hu, and X. Zou Preparation and antibacterial activity of chitosan nanoparticles Carbohydr. Res. 339 2004 2693 2700
52. E.I. Rabea, M.E.T. Badawy, C.V. Stevens, G. Smagghe, and W. Steurbaut Chitosan as antimicrobial agent: applications and mode of action Biomacromolecules 4 2003 1457 1465
53. A. Rai, A. Prabhune, and C.C. Perry Antibiotic mediated synthesis of gold nanoparticles with potent antimicrobial activity and their application in antimicrobial coatings J. Mater. Chem. 20 2010 6789 6798
54. P. Reynolds, and E. Somner Comparison of the target sites and mechanisms of action of glycopeptide and lipoglycodepsipeptide antibiotics Drugs Exp. Clin. Res. 16 1990 385 389
55. S. Roller, and N. Covill The antifungal properties of chitosan in laboratory media and apple juice Int. J. Food Microbiol. 47 1999 67 77
56. K. Roy, H.Q. Mao, S.K. Huang, and K.W. Leong Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy Nat. Med. 5 1999 387 391
57. G.J. Russell-Jones The potential use of receptor-mediated endocytosis for oral drug delivery Adv. Drug Deliv. Rev. 20 1996 83 97
58. B. Saha, A.K. Singh, A. Ghosh, and M. Bal Identification and characterization of a vancomycin resistant Staphylococcus aureus isolated from Kolkata (South Asia) J. Med. Microbiol. 57 2008 72 79
59. S. Saha, P.B. Savage, and M. Bal Enhancement of the efficacy of erythromycin in multiple antibiotic-resistant gram-negative bacterial pathogens J. Appl. Microbiol. 105 2008 822 828
60. E.J. Schmidt, J.S. Boswell, J.P. Walsh, M.M. Schellenberg, T.W. Winter, C. Li, G.W. Allman, and P.B. Savage Activities of cholic acid-derived antimicrobial agents against multidrug-resistant bacteria J. Antimicrob. Chemother. 47 2001 671 674
61. C. Schmitz, J. Hilpert, C. Jacobsen, C. Boensch, E.I. Christensen, F.C. Luft, and T.E. Willnow Megalin deficiency offers protection from renal aminoglycoside accumulation J. Biol. Chem. 277 2002 618 622
62. K. Sieradzki, M.G. Pinho, and A. Tomasz Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus J. Biol. Chem. 274 1999 18942 18946
63. I. Tamai, and A. Tsuji Carrier-mediated approaches for oral drug delivery Adv. Drug Deliv. Rev. 20 1996 5 32
64. I.M. Van der Lubben, J.C. Verhoef, G. Borchard, and H.E. Junginger Chitosan for mucosal vaccination Adv. Drug Deliv. Rev. 52 2001 139 144
65. A.J. Varma, S.V. Deshpande, and J.F. Kennedy Metal complexation by chitosan and its derivatives: a review Carbohydr. Polym. 55 2004 77 93
66. P. Vaudaux, A. Gjinovci, M. Bento, D. Li, J. Schrenzel, and P.D. Lew Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus Antimicrob. Agents Chemother. 49 2005 3789 3793
67. C. Walsh Deconstructing vancomycin Science 284 1999 442 443